According to a report by Reuters, “Kodak stock, which hovered in the $90 range in 1997, currently trades at about $2.42, a 40 percent drop over the past 12 months,” leading investors to “now see Kodak’s value in its lucrative portfolio of intellectual property.”

As a result, Kodak has adopted a so-called “poison pill” (more formally known as a shareholder rights plan) to protect the company from an unsolicited takeover while it tries to find a buyer for its IP assets.